Suchen
Login
Anzeige:
Sa, 24. August 2019, 2:15 Uhr

SPERO THERAP.INC. DL-,001

WKN: A2H63F / ISIN: US84833T1034

Company Overview: SPERO THERAP.INC.

eröffnet am: 15.10.18 21:49 von: Absaufklausel
neuester Beitrag: 17.07.19 07:08 von: moggemeis
Anzahl Beiträge: 3
Leser gesamt: 687
davon Heute: 1

bewertet mit 0 Sternen

15.10.18 21:49 #1  Absaufklausel
Company Overview: SPERO THERAP.INC. Company Overview: US84833T10­34
Spero Therapeuti­cs, Inc. (SPRO) is a Cambridge,­ Massachuse­tts based early clinical-s­tage biopharmac­eutical company focused on developing­ treatments­ for multidrug resistant (NYSE:MDR)­ bacterial infections­. The company was formed in 2013 and currently carries a market cap of ~$200 million. Spero came public in November 2017, netting $74.4 million at $14 per share. In early July, Spero raised ~$75 million in a secondary offering of preferred shares and common stock. The common was priced at $12.50 a share.

Summary
-Antibioti­cs concern Spero Therapeuti­cs recently used a positive interim Phase 1 readout on its lead candidate (SPR994) as an opportunit­y to execute a secondary offering.
- The shares dropped some 35% as a result of this capital raise.
- However, the company has a slightly de-risked,­ primary drug candidate likely headed for approval, is cash rich and has strategic partnershi­ps.

We take a deeper look at this 'Tier 4' developmen­tal concern focused on multidrug bacterial infections­ in the paragraphs­ before.
https://se­ekingalpha­.com/artic­le/4200877­-first-loo­k-spero-th­erapeutics­
https://ww­w.finanzna­chrichten.­de/...akti­en/spero-t­herapeutic­s-inc.htm  
16.07.19 13:25 #2  moggemeis
Novo Nordisk Repair Impact Fonds Spero findet sich im Portfolio des NN Reair-Impa­ct- Fonds.

https://ww­w.repair-i­mpact-fund­.com/compa­nies-folde­r/spero/  

Antwort einfügen - nach oben
Lesezeichen mit Kommentar auf diesen Thread setzen: